Dr. Mark Rubenstein, M.D.
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- Medical school
- Harvard Medical School (1995)
- Years since graduation
- 31
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 2,193
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1995Medical school: Harvard Medical School
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
FL license ME 85150
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Boca Raton Regional Hospital Boca Raton, FL
- Holy Cross Hospital Ft Lauderdale, FL
- Bethesda Hospital East Boynton Beach, FL
Medical groups
- Bartzokis Rubenstein Servoss MD Pl (7 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 2,193
- Services billed
- 9,394
- Patients’ average age
- 81
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 2,397 | 1,737 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,671 | 1,532 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 836 | 830 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 789 | 93 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 750 | 260 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 719 | 82 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 603 | 303 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 396 | 119 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 388 | 115 |
| Injection, regadenoson, 0.1 mg | 338 | 85 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 19 companies reported 120 payments worth $2,381 in total to this clinician.
| Food and Beverage | $2,381 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.